It is a targeted cancer therapy approved for patients with solid tumors caused by NTRK gene fusions. It works by blocking abnormal TRK fusion proteins that drive cancer growth. Oncologist recommends Vitrakvi 100mg Capsule uses in advanced solid tumor targeted therapy help slow disease progression and improve survival outcomes under medical supervision. You can visit Globans Pharma to know more.